Doceree raises US$ 35 million in Series B Funding
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity
The product is expected to start contributing meaningfully to the revenue from FY25
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
Subscribe To Our Newsletter & Stay Updated